A late-stage drug development company specific in oncology and endocrinology.

We look forward to reporting the final results from our ongoing European Phase 2 research in ovarian and endometrial tumor, this year later. .. Aeterna Zentaris granted FDA orphan-drug designation for AEZS-108 in ovarian cancer Aeterna Zentaris Inc. , a late-stage drug development company specific in oncology and endocrinology, announced that it has received from the U today.S. Food and Drug Administration , orphan-drug designation for AEZS-108, its doxorubicin targeted conjugate compound, for the treatment of ovarian cancer. AEZS-108 is currently in a Phase 2 trial in advanced advanced and ovarian endometrial cancer in Europe.After two times of experiencing an asthma assault, I was hearing the local news discussing people who had been calling in about an ‘odor’ from the tap drinking water. The city official said once a year they have to ‘purify the drinking water’ and that the fumes will ‘go away ultimately.’ The asthma converted into a cold, my eye got had been and sore swollen, and I was congested. When I started wheezing, my friend took me to a healthcare facility.’ ‘The ER doctor initial said I acquired the flu, he said I have to have pneumonia then.